MapLight Therapeutics, Inc.

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for patients suffering from debilitating central nervous system (CNS) disorders. The company was founded by leading experts in psychiatry and neuroscience to address the lack of circuit-specific pharmacotherapies available for patients with conditions like autism spectrum disorder, schizophrenia, Alzheimer's disease psychosis, and Parkinson's disease. MapLight's discovery platform utilizes a multi-pronged approach combining optogenetics, transcriptomics, and STARmap technology to identify and target neural circuits that are causally linked to disease.

MapLight has a strong track record of success in developing and advancing novel therapeutics, having already brought two product candidates into clinical trials. The company has garnered significant funding from investors and research foundations, demonstrating confidence in its mission and scientific capabilities. MapLight is committed to improving the lives of patients suffering from CNS disorders by developing treatments that target specific neural circuits and offer the potential for enhanced efficacy with reduced side effects.

MapLight Therapeutics offers a flexible vacation policy as well as weekly lunches and team building events ranging from sailing excursions to bowling nights. While the company provides competitive traditional benefits such as 401K matching, it emphasizes a strong company culture of cohesion and high-functioning teams, creating a work environment that inspires, mentors, and supports its employees.

MapLight Therapeutics offers competitive traditional benefits such as 401K matching, a flexible vacation policy, and weekly lunches. They also host team building events, ranging from sailing excursions to bowling nights.

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. Their mission is to develop targeted novel therapeutics to address the lack of circuit-specific pharmacotherapies available for patients struggling with conditions like Autism Spectrum Disorder, Schizophrenia, Alzheimer’s Disease Psychosis, and Parkinson’s Disease.

MapLight promotes a collaborative and high-functioning team environment where rigorous science, transparency, and integrity guide decision-making. While prioritizing ambitious goals and achieving transformative breakthroughs, the company fosters a culture of inspiration, mentoring, and support amongst employees, encouraging diverse backgrounds and skillsets to come together in a fun and dynamic atmosphere.

MapLight Therapeutics emphasizes a culture of diversity, equity, and inclusion, fostering a cohesive and high-functioning team where employees from diverse backgrounds and skill sets are valued and supported. They prioritize rigorous science, transparency, and integrity in their decision-making, while also encouraging inspiration, mentoring, and support among team members.